Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion.

Hikichi T, Higuchi M, Matsushita T, Kosaka S, Matsushita R, Takami K, Ohtsuka H, Kitamei H, Shioya S.

Br J Ophthalmol. 2014 Feb;98(2):195-9. doi: 10.1136/bjophthalmol-2013-303121. Epub 2013 Nov 8.

2.

Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion.

Higashiyama T, Sawada O, Kakinoki M, Sawada T, Kawamura H, Ohji M.

Acta Ophthalmol. 2013 Jun;91(4):318-24. doi: 10.1111/j.1755-3768.2011.02298.x. Epub 2011 Dec 1.

3.

Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.

Ding X, Li J, Hu X, Yu S, Pan J, Tang S.

Retina. 2011 May;31(5):838-45. doi: 10.1097/IAE.0b013e3181f4420d.

PMID:
21293319
4.

Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion.

Hoeh AE, Ach T, Schaal KB, Scheuerle AF, Dithmar S.

Graefes Arch Clin Exp Ophthalmol. 2009 Dec;247(12):1635-41. doi: 10.1007/s00417-009-1151-1. Epub 2009 Jul 26.

PMID:
19633982
5.

Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.

Jaissle GB, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G, Heimann H, Meyer CH; Retinal Vein Occlusion Study Group..

Graefes Arch Clin Exp Ophthalmol. 2011 Feb;249(2):183-92. doi: 10.1007/s00417-010-1470-2. Epub 2010 Aug 18.

6.

Recurrence of macular edema associated with branch retinal vein occlusion after intravitreal bevacizumab.

Hanada N, Iijima H, Sakurada Y, Imasawa M.

Jpn J Ophthalmol. 2012 Mar;56(2):165-74. doi: 10.1007/s10384-011-0113-4. Epub 2011 Dec 20.

PMID:
22183139
7.

Intravitreal bevacizumab associated with grid laser photocoagulation in macular edema secondary to branch retinal vein occlusion.

Salinas-Alamán A, Zarranz-Ventura J, Caire González-Jauregui JM, Sádaba-Echarri LM, Barrio-Barrio J, García-Layana A.

Eur J Ophthalmol. 2011 Jul-Aug;21(4):434-9. doi: 10.5301/EJO.2010.6101.

8.

Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion.

Sohn HJ, Han DH, Lee DY, Nam DH.

Acta Ophthalmol. 2014 May;92(3):e217-24. doi: 10.1111/aos.12219. Epub 2013 Jul 26.

9.

Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.

Puche N, Glacet A, Mimoun G, Zourdani A, Coscas G, Soubrane G.

Acta Ophthalmol. 2012 Jun;90(4):357-61. doi: 10.1111/j.1755-3768.2010.01913.x. Epub 2010 Jun 29.

10.

Intravitreal bevacizumab treatment for macular edema due to branch retinal vein occlusion in a clinical setting.

Siegel RA, Dreznik A, Mimouni K, Bor E, Weinberger D, Bourla DH.

Curr Eye Res. 2012 Sep;37(9):823-9. doi: 10.3109/02713683.2012.678542. Epub 2012 Jun 5.

PMID:
22668201
11.

Treatment of macular edema due to branch retinal vein occlusion with single or multiple intravitreal injections of bevacizumab.

Yunoki T, Miyakoshi A, Nakamura T, Fujita K, Fuchizawa C, Hayashi A.

Jpn J Ophthalmol. 2012 Mar;56(2):159-64. doi: 10.1007/s10384-011-0114-3. Epub 2012 Jan 14.

PMID:
22246387
12.

Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.

Mitry D, Bunce C, Charteris D.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD009510. doi: 10.1002/14651858.CD009510.pub2. Review.

PMID:
23440840
13.

The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion.

Ahmadi AA, Chuo JY, Banashkevich A, Ma PE, Maberley DA.

Can J Ophthalmol. 2009 Apr;44(2):154-9. doi: 10.3129/i09-040.

PMID:
19491948
14.

Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up.

Wu L, Arevalo JF, Roca JA, Maia M, Berrocal MH, Rodriguez FJ, Evans T, Costa RA, Cardillo J; Pan-American Collaborative Retina Study Group (PACORES)..

Retina. 2008 Feb;28(2):212-9. doi: 10.1097/IAE.0b013e3181619bee.

PMID:
18301025
15.

Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion:results after 12 months and multiple regression analysis.

Kondo M, Kondo N, Ito Y, Kachi S, Kikuchi M, Yasuma TR, Ota I, Kensaku M, Terasaki H.

Retina. 2009 Oct;29(9):1242-8. doi: 10.1097/IAE.0b013e3181aa8e20.

PMID:
19672216
16.

Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.

Mayer WJ, Remy M, Wolf A, Kook D, Kampik A, Ulbig M, Reznicek L, Haritoglou C.

Ophthalmologica. 2012;228(2):110-6. doi: 10.1159/000338732. Epub 2012 Jun 23.

PMID:
22739239
17.

Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion.

Kang HM, Chung EJ, Kim YM, Koh HJ.

Graefes Arch Clin Exp Ophthalmol. 2013 Feb;251(2):501-8. doi: 10.1007/s00417-012-2067-8. Epub 2012 Jun 1.

PMID:
22653439
18.

Intravitreal injection of bevacizumab combined with macular grid laser photocoagulation for macular edema in branch retinal vein occlusion.

Hayashi A, Yunoki T, Miyakoshi A, Mitarai K, Fujino T, Yanagisawa S.

Jpn J Ophthalmol. 2011 Nov;55(6):625-31. doi: 10.1007/s10384-011-0087-2. Epub 2011 Sep 9.

PMID:
21909658
19.

Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusion.

Shimura M, Yasuda K.

Br J Ophthalmol. 2015 Feb;99(2):215-9. doi: 10.1136/bjophthalmol-2013-304720. Epub 2014 Sep 2.

PMID:
25185254
20.

Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.

Cheng KC, Wu WC, Chen KJ.

Eye (Lond). 2009 Nov;23(11):2023-33. doi: 10.1038/eye.2009.230. Epub 2009 Oct 2.

PMID:
19798117

Supplemental Content

Support Center